WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
Secrets of the workout queen of middle England: 51
Across China: Medicinal Plant Brews up Sweet Life for Locals
Insider Q&A: CIA's chief technologist's cautious embrace of generative AI
Dying with Dignity, Living with Love
Policies yield key results in Xiong'an
Mystery artist who erected signs comparing pothole
Xinjiang Story: Uygur Dancer Blends Folk Elegance with Modern Street Beats
Kate Hudson hits the stage to debut songs from her new album Glorious at star
Dancer Sheds Light on Living with a Hearing Disability